Net Lease Office Properties announced the sale of three office properties for a total of approximately $34.4 million. The properties include vacant offices in Plano, TX and King of Prussia, PA, and an Arbella Insurance property in Quincy, MA. The company declared a special cash distribution of $1.50 per common share, totaling about $22 million, payable on December 1, 2026. This distribution adds to a total of $24.19 per share declared since the company was spun off in November 2023, reflecting strong returns to shareholders.
Net Lease Office Properties' special cash distribution announcement comes as a backdrop for this Pluang market snapshot. For readers following the Real Estate sector, here is Pluang's market snapshot as of Nov 05, 2026 03:31 WIB: All 47 priced Real Estate-sector US stocks tradable on Pluang rose today. Notable movers include Opendoor Technologies Inc at USD 2.01 with a 15.52% increase and 97% buy order activity, Compass Inc. Class A at USD 10.10 up 8.37%, and Alexandria Real Estate Equities Inc at USD 45.08, which saw a 6.61% rise but 100% sell order activity.
NOVAGOLD shareholders approved a transaction for New NOVAGOLD to acquire the remaining 40% interest in the Donlin Gold project from Paulson Advisers, increasing NOVAGOLD's ownership from 60% to 100%. This consolidation makes New NOVAGOLD the ultimate...
Fox Factory Holding Corp. has appointed Troy Henige as its new Chief Technology Officer (CTO) to lead the company's technology vision, strategy, and product roadmap. This new role aims to enhance innovation, connect engineering strengths across the c...
3M Company has reached a historic $7.35 billion settlement to resolve personal injury claims related to exposure to PFAS, toxic chemicals known as "forever chemicals." The settlement covers about 99% of existing claims, potentially benefiting 115,000...
The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...
Royalty Pharma plc is the global leader in acquiring biopharmaceutical royalties, focusing on de-risked, post-proof-of-concept assets. The company offers investors exposure to blockbuster therapies with attractive risk-adjusted returns, including aro...
